Marcia Belvin, SVP, Chief Scientific Officer at CytomX Therapeutics, Inc. (CTMX), sold 19,512 shares at $0.60 ($12K) on 2025-03-18, disclosed to the SEC on 2025-03-20.
Open-market sale of $12k CTMX by SVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CTMX | SELL | 2024-08-22 | $5K | — | Filing → |
| CTMX | SELL | 2024-03-21 | $27K | — | Filing → |
| CTMX | SELL | 2023-12-22 | $6K | — | Filing → |